MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-13-2025
Celcuity Operating Expenses 2011-2026 | CELC
Annual Operating Expenses Celcuity
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113 M | 66.2 M | 39.4 M | 28.4 M | 9.56 M | 7.81 M | 7.93 M | 5.95 M | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 113 M | 5.95 M | 34.8 M |
Quarterly Operating Expenses Celcuity
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.8 M | 44 M | 36.1 M | - | 30.1 M | 24.3 M | 22.5 M | - | 18.9 M | 15.1 M | 12.5 M | - | 10.6 M | 9.6 M | 7.51 M | - | 5.6 M | 13.6 M | 2.79 M | - | 2.48 M | 2.21 M | 2.31 M | - | 2.09 M | 1.84 M | 1.97 M | - | 1.98 M | 1.93 M | 2.08 M | - | 1.53 M | 1.61 M | 994 K | - | 878 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 44 M | 878 K | 11.4 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 21.01 | 8.92 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 22.01 | 11.81 % | $ 237 M |  China |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 5.72 | 2.88 % | $ 168 M | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.62 | 1.89 % | $ 2.06 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 12.64 | 20.15 % | $ 359 M | Israel |
 |
DexCom
DXCM
|
1.69 B | $ 67.67 | 1.7 % | $ 26.1 B | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 38.51 | -0.08 % | $ 1.07 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.53 | -0.21 % | $ 18.8 B | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 234.56 | 1.82 % | $ 171 B | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 25.48 | -0.43 % | $ 770 M | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 20.02 | 4.6 % | $ 1.08 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.18 | 0.63 % | $ 101 K | USA |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 233.99 | 3.82 % | $ 42.4 B | USA |
 |
Guardant Health
GH
|
226 M | $ 102.55 | 0.79 % | $ 12.6 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Illumina
ILMN
|
3.69 B | $ 140.15 | 4.32 % | $ 22.3 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 208.19 | 2.86 % | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.19 | 0.73 % | $ 561 M | USA |
 |
NeoGenomics
NEO
|
382 M | $ 12.18 | 3.53 % | $ 1.54 B | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 7.3 | 4.21 % | $ 1.58 B | USA |
 |
Natera
NTRA
|
258 M | $ 235.89 | 3.08 % | $ 23.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 173.85 | 0.13 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.05 | -6.35 % | $ 785 M | USA |
 |
OPKO Health
OPK
|
217 M | $ 1.26 | -0.39 % | $ 874 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 253.05 | 0.55 % | $ 21.2 B | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 197.18 | 4.51 % | $ 16.3 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 682.72 | 1.9 % | $ 56.3 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 69.25 | 2.94 % | $ 4.79 B | USA |
 |
Pacific Biosciences of California
PACB
|
387 M | $ 1.96 | 6.52 % | $ 497 M | USA |
 |
Agilent Technologies
A
|
1.99 B | $ 142.17 | 3.08 % | $ 43.2 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 439.83 | 2.01 % | $ 30.6 B |  Schweiz |
 |
Organovo Holdings
ONVO
|
23.3 M | - | -2.3 % | $ 19.4 M | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.56 | 1.19 % | $ 5.88 M | USA |